|
市場調查報告書
改善患者照護及降低成本策略
Beyond Disease Management: Strategies for Improving Patient Care and Cutting Costs
|
本報告已在2011年12月21日停止出版。
本報告書內容包括：美國疾病管理概要及Medicare概要、患者動向、未來預測等。內容綱要摘記如下：
實施概要
介紹
疾病管理的發展及相關策略
疾病管理及相關策略的需求提高
患者登錄的課題
雇用者對疾病管理的看法
Medicare的行動方案
Medicaid及國家的行動
未來預測及對藥品產業造成的影響
補充資料
- 何謂疾病管理？
- 在佛羅里達州製造業者提供支援的疾病管理計畫
表
- 美國雇用者的實況及今後照護管理對策的利用
- 製藥企業支援的疾病管理計畫獲得National committee for Quality Assurance許可
圖
- 提供醫療補助及疾病管理計畫的各種規模的美國雇用者比例
- 美國雇用者的疾病管理計畫包含的内容
- 提供疾病管理的健康維持機構的疾病管理計畫包含的内容
- 美國雇用者對於做為費用控制對策的疾病管理效果的認知
Abstract
Introduction
Disease management has become a common term in the U.S. health care system.
Yet, the more widely the term has been adopted, the more diffuse the defi
nition of this health care strategy has become. Whatever the actual defi
nition, many employers regard cost-containment as a key objective of DM
initiatives. DM activity is focused largely on several highly prevalent
chronic disorders-diabetes, asthma, hypertension, and dyslipidemia.
Manufacturers of therapies need to prepare for the impact of DM on these
markets.
Get the Answers You Need to Shape Your Strategy
- A 2006 survey found that 76% of employers saw a connection between
employees' health status and employees' productivity. How can
pharmaceutical companies underscore the positive impact of good health on
productivity?
- The most basic challenge in recruiting participants for any form of care
management program is identifying suitable candidates for enrollment. How
do health plans stratify patients into risk categories? How do they use this
information to project health care costs for patients?
- Disease management programs will likely alter established prescribing
patterns. What effects will these programs have on drug sales? Which
classes will be most affected?
- For most employers, cost-containment is an essential objective of care
management. How do companies rate the effectiveness of these plans as a
cost-cutting measure?
Scope
- Disease management overview: defi nition and evolution of disease
management and related strategies.
- Employers' views on disease management: fi ndings from an employer
health benefi t survey.
- Challenges of patient enrollment: identifying candidates,
persuading members to sign up for the program, whether to offer incentives to
employees.
- Disease management in Medicare: how to apply the DM concept to
Medicare benefi ciaries.
- State initiative: several state governments have begun to explore
the potential of DM.
- Outlook: implications of disease management for the pharmaceutical
industry.
Table of Contents
- Executive Summary
- Strategic Considerations
- Stakeholder Implications
- Introduction
- Evolution of Disease Management and Related Strategies
- Growing Demand for Disease Management and Related Strategies
- Challenges of Patient Enrollment
- Employers' Views on Disease Management
- Medicare Initiatives
- Medicaid and State Initiatives
- Support from CMS
- State Initiatives
- Outlook and Implications for the Pharmaceutical Industry
Sidebars
- What Is Disease Management?
- Florida Gives Manufacturer-Sponsored Disease Management Programs a Second
Chance
Tables
- 1. U.S. Employers' Actual and Potential Use of Select Care Management
Measures
- 2. Pharmaceutical Manufacturer-Sponsored Disease Management Programs
Certified by the National Committee for Quality Assurance, November 2007
Figures
- 1. Percentage of U.S. Employers of Various Sizes That Offer Health Benefi
ts and Disease Management Programs, 2006
- 2. Coverage of Key Indications in U.S. Employers' Disease Management
Programs, 2006
- 3. Coverage of Select Indications in Disease Management Programs of Health
Maintenance Organizations That Offer Disease Management, 2006
- 4. U.S. Employers' Perceptions of the Effectiveness of Disease Management
as a Cost-Containment Measure, 2007
|
